

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytoplasmic mRNA processing body assembly (GO:0033962) | 8.84896107 |
| 2 | tricarboxylic acid cycle (GO:0006099) | 8.81154887 |
| 3 | peptidyl-arginine methylation (GO:0018216) | 8.80537492 |
| 4 | peptidyl-arginine N-methylation (GO:0035246) | 8.80537492 |
| 5 | positive regulation of mitochondrial fission (GO:0090141) | 8.62240925 |
| 6 | histone arginine methylation (GO:0034969) | 7.87320825 |
| 7 | nerve growth factor signaling pathway (GO:0038180) | 7.34029667 |
| 8 | regulation of mitochondrial depolarization (GO:0051900) | 7.21402498 |
| 9 | glomerular visceral epithelial cell development (GO:0072015) | 7.05825091 |
| 10 | male sex determination (GO:0030238) | 6.99079742 |
| 11 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 6.69537989 |
| 12 | pyrimidine nucleotide catabolic process (GO:0006244) | 6.67143703 |
| 13 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 6.65895250 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 6.65129239 |
| 15 | regulation of mitochondrial fission (GO:0090140) | 6.63024940 |
| 16 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 6.57078591 |
| 17 | mitotic cell cycle arrest (GO:0071850) | 6.39658239 |
| 18 | glomerular epithelial cell development (GO:0072310) | 6.21145688 |
| 19 | negative regulation of activin receptor signaling pathway (GO:0032926) | 6.02184969 |
| 20 | protein K6-linked ubiquitination (GO:0085020) | 5.98854649 |
| 21 | daunorubicin metabolic process (GO:0044597) | 5.78148221 |
| 22 | polyketide metabolic process (GO:0030638) | 5.78148221 |
| 23 | doxorubicin metabolic process (GO:0044598) | 5.78148221 |
| 24 | negative regulation of cell aging (GO:0090344) | 5.76009643 |
| 25 | base-excision repair, AP site formation (GO:0006285) | 5.63143339 |
| 26 | peptidyl-arginine modification (GO:0018195) | 5.59207141 |
| 27 | positive regulation of protein homooligomerization (GO:0032464) | 5.52832158 |
| 28 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 5.47290764 |
| 29 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 5.47290764 |
| 30 | regulation of glycogen (starch) synthase activity (GO:2000465) | 5.34082700 |
| 31 | regulation of protein homooligomerization (GO:0032462) | 5.25592635 |
| 32 | positive regulation of growth hormone secretion (GO:0060124) | 5.12717574 |
| 33 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.11484100 |
| 34 | muscle organ morphogenesis (GO:0048644) | 5.00744031 |
| 35 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 4.90705281 |
| 36 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 4.90705281 |
| 37 | spermatid development (GO:0007286) | 4.78923193 |
| 38 | lung-associated mesenchyme development (GO:0060484) | 4.56403664 |
| 39 | positive regulation of mRNA 3-end processing (GO:0031442) | 4.44635802 |
| 40 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 4.39697899 |
| 41 | meiosis I (GO:0007127) | 4.23822298 |
| 42 | cellular response to nerve growth factor stimulus (GO:1990090) | 4.19310983 |
| 43 | response to nerve growth factor (GO:1990089) | 4.19310983 |
| 44 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.14131564 |
| 45 | peristalsis (GO:0030432) | 4.10262346 |
| 46 | regulation of mRNA 3-end processing (GO:0031440) | 4.03828894 |
| 47 | sulfation (GO:0051923) | 3.93793905 |
| 48 | reciprocal meiotic recombination (GO:0007131) | 3.92061838 |
| 49 | reciprocal DNA recombination (GO:0035825) | 3.92061838 |
| 50 | regulation of timing of cell differentiation (GO:0048505) | 3.91189682 |
| 51 | deoxyribonucleotide catabolic process (GO:0009264) | 3.86847416 |
| 52 | neuronal action potential (GO:0019228) | 3.86215538 |
| 53 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.83175407 |
| 54 | positive regulation of mRNA catabolic process (GO:0061014) | 3.82166010 |
| 55 | regulation of cell aging (GO:0090342) | 3.76389171 |
| 56 | sex determination (GO:0007530) | 3.75493105 |
| 57 | positive regulation of protein oligomerization (GO:0032461) | 3.61723657 |
| 58 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.58078770 |
| 59 | SMAD protein signal transduction (GO:0060395) | 3.57740125 |
| 60 | fibroblast migration (GO:0010761) | 3.57374278 |
| 61 | regulation of membrane depolarization (GO:0003254) | 3.57244172 |
| 62 | deoxyribose phosphate catabolic process (GO:0046386) | 3.55343418 |
| 63 | positive regulation of phosphatase activity (GO:0010922) | 3.48120796 |
| 64 | non-recombinational repair (GO:0000726) | 3.38932635 |
| 65 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.38932635 |
| 66 | regulation of development, heterochronic (GO:0040034) | 3.33502650 |
| 67 | regulation of protein oligomerization (GO:0032459) | 3.31403430 |
| 68 | primary alcohol catabolic process (GO:0034310) | 3.29398859 |
| 69 | regulation of mRNA catabolic process (GO:0061013) | 3.28829062 |
| 70 | regulation of growth hormone secretion (GO:0060123) | 3.25015840 |
| 71 | negative regulation of protein oligomerization (GO:0032460) | 3.19626586 |
| 72 | auditory receptor cell stereocilium organization (GO:0060088) | 3.18706016 |
| 73 | negative regulation of epidermis development (GO:0045683) | 3.16169060 |
| 74 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.15124679 |
| 75 | ER overload response (GO:0006983) | 3.14381685 |
| 76 | positive regulation of p38MAPK cascade (GO:1900745) | 3.13727909 |
| 77 | embryonic digestive tract development (GO:0048566) | 3.12138865 |
| 78 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10475704 |
| 79 | regulation of B cell differentiation (GO:0045577) | 3.03479262 |
| 80 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.00733011 |
| 81 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.00733011 |
| 82 | response to redox state (GO:0051775) | 2.99163007 |
| 83 | B cell homeostasis (GO:0001782) | 2.98953792 |
| 84 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.98435638 |
| 85 | multicellular organismal aging (GO:0010259) | 2.94824964 |
| 86 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.92962649 |
| 87 | protein import into peroxisome matrix (GO:0016558) | 2.92879554 |
| 88 | positive regulation of icosanoid secretion (GO:0032305) | 2.92266551 |
| 89 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.89592247 |
| 90 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.89592247 |
| 91 | DNA excision (GO:0044349) | 2.82240386 |
| 92 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 2.82240386 |
| 93 | phasic smooth muscle contraction (GO:0014821) | 2.81231533 |
| 94 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.80945830 |
| 95 | positive regulation of mRNA processing (GO:0050685) | 2.79358893 |
| 96 | protein autoubiquitination (GO:0051865) | 2.78206003 |
| 97 | positive regulation of fatty acid transport (GO:2000193) | 2.76983660 |
| 98 | gene silencing by RNA (GO:0031047) | 2.74920399 |
| 99 | succinate metabolic process (GO:0006105) | 12.4628254 |
| 100 | peptidyl-arginine omega-N-methylation (GO:0035247) | 10.0914932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 8.10862477 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 4.14524783 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.91851790 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.79131126 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.52198493 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.32764295 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.03679184 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.85836870 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85623044 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.84979366 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09161920 |
| 12 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 2.01567010 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 10.5237359 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90899056 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90052157 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78524358 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.77798370 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75280698 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.70678618 |
| 20 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.70315836 |
| 21 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.62933863 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.62110160 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59274663 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56716409 |
| 25 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.47817828 |
| 26 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47817828 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47714173 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45566290 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34789943 |
| 30 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.30575677 |
| 31 | ERA_21632823_ChIP-Seq_H3396_Human | 1.29657949 |
| 32 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26734248 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26536577 |
| 34 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.25434737 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25268199 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22155732 |
| 37 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20570420 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16545294 |
| 39 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13158041 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12932962 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12280487 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12123893 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11459908 |
| 44 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10552507 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09986314 |
| 46 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 1.08058652 |
| 47 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06179493 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05804384 |
| 49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05262497 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.04158771 |
| 51 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03506960 |
| 52 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00893743 |
| 53 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99288981 |
| 54 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97164250 |
| 55 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96619252 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96152489 |
| 57 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94528802 |
| 58 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.93202830 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92161399 |
| 60 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.89514903 |
| 61 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89160942 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.88572872 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88064149 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88064149 |
| 65 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.87528806 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86171370 |
| 67 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85239497 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84363853 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83386713 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83307175 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82905117 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.82747778 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82438376 |
| 74 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.81828707 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81316570 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81182360 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80577299 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80514771 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78854430 |
| 80 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.78631274 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78082271 |
| 82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.78079290 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77429951 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.75965408 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75782520 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.75765783 |
| 87 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75346155 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74963186 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.74512046 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74050751 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73459067 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 0.73337218 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72324661 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.70886419 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.70749280 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70683734 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70126241 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69557013 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.69539914 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69483330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005365_abnormal_bile_salt | 6.07179316 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.25941952 |
| 3 | MP0008877_abnormal_DNA_methylation | 3.67900985 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 2.85171728 |
| 5 | MP0000751_myopathy | 2.44239324 |
| 6 | MP0009278_abnormal_bone_marrow | 2.34027620 |
| 7 | MP0003787_abnormal_imprinting | 2.32534672 |
| 8 | MP0000747_muscle_weakness | 2.23109562 |
| 9 | MP0003868_abnormal_feces_composition | 2.20597893 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.10740053 |
| 11 | MP0001485_abnormal_pinna_reflex | 2.06604429 |
| 12 | MP0003567_abnormal_fetal_cardiomyocyte | 2.06091096 |
| 13 | MP0000749_muscle_degeneration | 2.01226092 |
| 14 | MP0009764_decreased_sensitivity_to | 2.00478623 |
| 15 | MP0000566_synostosis | 10.6289951 |
| 16 | MP0009046_muscle_twitch | 1.93488405 |
| 17 | MP0003283_abnormal_digestive_organ | 1.85273685 |
| 18 | MP0002332_abnormal_exercise_endurance | 1.85192621 |
| 19 | MP0003221_abnormal_cardiomyocyte_apopto | 1.77976504 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.76001971 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.68545110 |
| 22 | MP0001299_abnormal_eye_distance/ | 1.67279281 |
| 23 | MP0008260_abnormal_autophagy | 1.64855105 |
| 24 | MP0003121_genomic_imprinting | 1.62621191 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.55561534 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.54320852 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51887727 |
| 28 | MP0003195_calcinosis | 1.40471060 |
| 29 | MP0002102_abnormal_ear_morphology | 1.39197082 |
| 30 | MP0002751_abnormal_autonomic_nervous | 1.38564460 |
| 31 | MP0003122_maternal_imprinting | 1.38315195 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.33255328 |
| 33 | MP0005410_abnormal_fertilization | 1.29543962 |
| 34 | MP0000470_abnormal_stomach_morphology | 1.27671391 |
| 35 | MP0009053_abnormal_anal_canal | 1.26145181 |
| 36 | MP0009840_abnormal_foam_cell | 1.25577932 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.24942371 |
| 38 | MP0002210_abnormal_sex_determination | 1.24541827 |
| 39 | MP0001145_abnormal_male_reproductive | 1.24342122 |
| 40 | MP0000490_abnormal_crypts_of | 1.24312906 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.24005731 |
| 42 | MP0000681_abnormal_thyroid_gland | 1.21795983 |
| 43 | MP0005083_abnormal_biliary_tract | 1.21302124 |
| 44 | MP0005332_abnormal_amino_acid | 1.20191174 |
| 45 | MP0004742_abnormal_vestibular_system | 1.20049926 |
| 46 | MP0001929_abnormal_gametogenesis | 1.18237889 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.14906401 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.10957699 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.07421956 |
| 50 | MP0000653_abnormal_sex_gland | 1.06740071 |
| 51 | MP0005360_urolithiasis | 0.98747076 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 0.97438455 |
| 53 | MP0002111_abnormal_tail_morphology | 0.95919370 |
| 54 | MP0005646_abnormal_pituitary_gland | 0.95687777 |
| 55 | MP0004484_altered_response_of | 0.94224453 |
| 56 | MP0003936_abnormal_reproductive_system | 0.93551469 |
| 57 | MP0005266_abnormal_metabolism | 0.90848851 |
| 58 | MP0002932_abnormal_joint_morphology | 0.89009620 |
| 59 | MP0001944_abnormal_pancreas_morphology | 0.84985020 |
| 60 | MP0008057_abnormal_DNA_replication | 0.84881994 |
| 61 | MP0001501_abnormal_sleep_pattern | 0.84615654 |
| 62 | MP0002735_abnormal_chemical_nociception | 0.83729963 |
| 63 | MP0005386_behavior/neurological_phenoty | 0.83434792 |
| 64 | MP0004924_abnormal_behavior | 0.83434792 |
| 65 | MP0009697_abnormal_copulation | 0.83197864 |
| 66 | MP0001727_abnormal_embryo_implantation | 0.81600201 |
| 67 | MP0001756_abnormal_urination | 0.81308340 |
| 68 | MP0002064_seizures | 0.79847174 |
| 69 | MP0001664_abnormal_digestion | 0.77522066 |
| 70 | MP0002938_white_spotting | 0.75965596 |
| 71 | MP0002653_abnormal_ependyma_morphology | 0.75962587 |
| 72 | MP0002272_abnormal_nervous_system | 0.75908826 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.75667343 |
| 74 | MP0010329_abnormal_lipoprotein_level | 0.75625870 |
| 75 | MP0001544_abnormal_cardiovascular_syste | 0.75194395 |
| 76 | MP0005385_cardiovascular_system_phenoty | 0.75194395 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.74247168 |
| 78 | MP0000372_irregular_coat_pigmentation | 0.73199140 |
| 79 | MP0003942_abnormal_urinary_system | 0.69010279 |
| 80 | MP0003698_abnormal_male_reproductive | 0.68230603 |
| 81 | MP0000477_abnormal_intestine_morphology | 0.67270530 |
| 82 | MP0004130_abnormal_muscle_cell | 0.66588330 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.64842798 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.64791303 |
| 85 | MP0003119_abnormal_digestive_system | 0.63697314 |
| 86 | MP0005369_muscle_phenotype | 0.62909972 |
| 87 | MP0002160_abnormal_reproductive_system | 0.62422661 |
| 88 | MP0005389_reproductive_system_phenotype | 0.61312882 |
| 89 | MP0001968_abnormal_touch/_nociception | 0.60282859 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.58079960 |
| 91 | MP0001970_abnormal_pain_threshold | 0.57599778 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.57212518 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.56810752 |
| 94 | MP0009745_abnormal_behavioral_response | 0.56499107 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.56240869 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 0.53771658 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.53206728 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.52682129 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52523152 |
| 100 | MP0008569_lethality_at_weaning | 0.51437060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.90459796 |
| 2 | Decreased central vision (HP:0007663) | 5.79527215 |
| 3 | Humeroradial synostosis (HP:0003041) | 5.72416079 |
| 4 | Synostosis involving the elbow (HP:0003938) | 5.72416079 |
| 5 | Dicarboxylic aciduria (HP:0003215) | 5.32614568 |
| 6 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 5.32614568 |
| 7 | Unsteady gait (HP:0002317) | 5.28666121 |
| 8 | Hypophosphatemia (HP:0002148) | 4.44911830 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 4.10510089 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.01449403 |
| 11 | Pheochromocytoma (HP:0002666) | 3.84721081 |
| 12 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.63215293 |
| 13 | Tetraparesis (HP:0002273) | 3.50601149 |
| 14 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.30445459 |
| 15 | Neuroendocrine neoplasm (HP:0100634) | 3.21311223 |
| 16 | Hypoplasia of the thymus (HP:0000778) | 3.19124381 |
| 17 | Amblyopia (HP:0000646) | 3.15965484 |
| 18 | Turricephaly (HP:0000262) | 3.07216047 |
| 19 | Prolonged neonatal jaundice (HP:0006579) | 3.06809013 |
| 20 | Cubitus valgus (HP:0002967) | 3.04651312 |
| 21 | Cerebral hemorrhage (HP:0001342) | 2.98902876 |
| 22 | Upper limb muscle weakness (HP:0003484) | 2.89597109 |
| 23 | Clitoromegaly (HP:0000057) | 2.81750365 |
| 24 | Optic nerve hypoplasia (HP:0000609) | 2.79859513 |
| 25 | Hand muscle atrophy (HP:0009130) | 2.71776334 |
| 26 | Conjunctival hamartoma (HP:0100780) | 2.70193907 |
| 27 | Nonimmune hydrops fetalis (HP:0001790) | 2.52262470 |
| 28 | Hyperglycinemia (HP:0002154) | 2.50750081 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 2.44991351 |
| 30 | Meningioma (HP:0002858) | 2.44270149 |
| 31 | Increased serum pyruvate (HP:0003542) | 2.42924347 |
| 32 | Respiratory failure (HP:0002878) | 2.38769535 |
| 33 | Febrile seizures (HP:0002373) | 2.35621879 |
| 34 | Pancreatic cysts (HP:0001737) | 2.35183633 |
| 35 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.32640098 |
| 36 | Pendular nystagmus (HP:0012043) | 2.32562924 |
| 37 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.30205145 |
| 38 | Short 1st metacarpal (HP:0010034) | 2.30205145 |
| 39 | Hydroxyprolinuria (HP:0003080) | 2.27163685 |
| 40 | Abnormality of proline metabolism (HP:0010907) | 2.27163685 |
| 41 | Limb hypertonia (HP:0002509) | 2.27010017 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.25860710 |
| 43 | Steatorrhea (HP:0002570) | 2.24516670 |
| 44 | Neoplasm of the adrenal gland (HP:0100631) | 2.24475405 |
| 45 | Bone cyst (HP:0012062) | 2.23366055 |
| 46 | Abnormality of glycolysis (HP:0004366) | 2.22047494 |
| 47 | Intellectual disability, severe (HP:0010864) | 2.20187586 |
| 48 | Oral leukoplakia (HP:0002745) | 2.19893873 |
| 49 | Hamartoma of the eye (HP:0010568) | 2.17132813 |
| 50 | Brushfield spots (HP:0001088) | 2.13556869 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.12958470 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.12958470 |
| 53 | Tubulointerstitial fibrosis (HP:0005576) | 2.10788057 |
| 54 | Hypoalphalipoproteinemia (HP:0003233) | 2.07995726 |
| 55 | Abnormality of the 1st metacarpal (HP:0010009) | 2.06118961 |
| 56 | Respiratory distress (HP:0002098) | 2.05404336 |
| 57 | Abnormality of the vocal cords (HP:0008777) | 2.05203150 |
| 58 | Hemiplegia (HP:0002301) | 2.04043857 |
| 59 | Hyperventilation (HP:0002883) | 17.3514481 |
| 60 | Methylmalonic aciduria (HP:0012120) | 11.0901698 |
| 61 | Focal motor seizures (HP:0011153) | 1.99510718 |
| 62 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.97181966 |
| 63 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97004114 |
| 64 | Hyperhidrosis (HP:0000975) | 1.95010314 |
| 65 | Synostosis involving bones of the feet (HP:0009140) | 1.93944879 |
| 66 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.93944879 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91925239 |
| 68 | Cystic liver disease (HP:0006706) | 1.91128177 |
| 69 | Hyperglycinuria (HP:0003108) | 1.87930681 |
| 70 | Amelogenesis imperfecta (HP:0000705) | 1.83157212 |
| 71 | Lactic acidosis (HP:0003128) | 1.83007876 |
| 72 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82620221 |
| 73 | Abnormality of glycine metabolism (HP:0010895) | 1.82620221 |
| 74 | Furrowed tongue (HP:0000221) | 1.82270435 |
| 75 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.81405406 |
| 76 | Supernumerary spleens (HP:0009799) | 1.79977348 |
| 77 | Long foot (HP:0001833) | 1.78565979 |
| 78 | Pancreatic fibrosis (HP:0100732) | 1.77921488 |
| 79 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72475128 |
| 80 | Epileptic encephalopathy (HP:0200134) | 1.71993532 |
| 81 | Fat malabsorption (HP:0002630) | 1.70488534 |
| 82 | Confusion (HP:0001289) | 1.68532310 |
| 83 | Palpebral edema (HP:0100540) | 1.67437410 |
| 84 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.65028265 |
| 85 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.63771043 |
| 86 | Type II lissencephaly (HP:0007260) | 1.63339882 |
| 87 | Hyperglycemia (HP:0003074) | 1.58038262 |
| 88 | Enlarged kidneys (HP:0000105) | 1.57294198 |
| 89 | Pili torti (HP:0003777) | 1.56778536 |
| 90 | Abnormal biliary tract morphology (HP:0012440) | 1.54514580 |
| 91 | Bile duct proliferation (HP:0001408) | 1.52111379 |
| 92 | Abnormal biliary tract physiology (HP:0012439) | 1.52111379 |
| 93 | Synostosis involving bones of the hand (HP:0004278) | 1.51460429 |
| 94 | Severe visual impairment (HP:0001141) | 1.49822528 |
| 95 | Abnormality of the clitoris (HP:0000056) | 1.49156745 |
| 96 | Polar cataract (HP:0010696) | 1.45151458 |
| 97 | Progressive inability to walk (HP:0002505) | 1.44519162 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.44494244 |
| 99 | Long clavicles (HP:0000890) | 1.43636571 |
| 100 | Ketosis (HP:0001946) | 1.43324650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK8 | 6.87037459 |
| 2 | MAP3K4 | 6.81567644 |
| 3 | MST1R | 3.44472015 |
| 4 | DYRK1B | 2.99981229 |
| 5 | GRK7 | 2.95345047 |
| 6 | CSNK1G3 | 2.86256799 |
| 7 | CSNK1A1L | 2.84710819 |
| 8 | ZAK | 2.79261532 |
| 9 | CASK | 2.53545025 |
| 10 | TGFBR2 | 2.50469502 |
| 11 | MOS | 2.47023723 |
| 12 | GRK5 | 2.40764769 |
| 13 | CSNK1G2 | 2.38416352 |
| 14 | DYRK3 | 2.28784311 |
| 15 | CSNK1G1 | 2.23688028 |
| 16 | MST4 | 2.15211928 |
| 17 | FRK | 2.07735076 |
| 18 | VRK2 | 1.98882704 |
| 19 | CDK19 | 1.95224842 |
| 20 | STK10 | 1.92001336 |
| 21 | BRD4 | 1.60522157 |
| 22 | MET | 1.40845994 |
| 23 | SMG1 | 1.35811576 |
| 24 | MARK1 | 1.30137991 |
| 25 | MAP2K7 | 1.26790020 |
| 26 | KDR | 1.21932693 |
| 27 | NUAK1 | 1.15462510 |
| 28 | STK38L | 1.12270458 |
| 29 | TAF1 | 1.10641734 |
| 30 | TLK1 | 1.05277891 |
| 31 | PRKCI | 0.92054658 |
| 32 | EIF2AK2 | 0.91364961 |
| 33 | CLK1 | 0.91166431 |
| 34 | MAP3K7 | 0.85183058 |
| 35 | GRK1 | 0.83734102 |
| 36 | BLK | 0.83686826 |
| 37 | PKN1 | 0.79933140 |
| 38 | RPS6KA6 | 0.73129256 |
| 39 | DYRK2 | 0.72199028 |
| 40 | TRIB3 | 0.71832426 |
| 41 | STK11 | 0.68147789 |
| 42 | VRK1 | 0.67469983 |
| 43 | LIMK1 | 0.65545417 |
| 44 | CAMK4 | 0.65355091 |
| 45 | OBSCN | 0.65353611 |
| 46 | IRAK3 | 0.65243886 |
| 47 | MAP3K13 | 0.64680804 |
| 48 | ERN1 | 0.62320297 |
| 49 | EPHA2 | 0.57640294 |
| 50 | ERBB4 | 0.56646947 |
| 51 | DAPK2 | 0.56252198 |
| 52 | RPS6KA5 | 0.51135370 |
| 53 | MAP4K1 | 0.50588272 |
| 54 | MAPK7 | 0.49949577 |
| 55 | NME1 | 0.43967999 |
| 56 | TTK | 0.42750208 |
| 57 | AURKA | 0.40985863 |
| 58 | PHKG2 | 0.40358318 |
| 59 | PHKG1 | 0.40358318 |
| 60 | CAMKK2 | 0.40014718 |
| 61 | STK4 | 0.39749717 |
| 62 | MAPK12 | 0.37740315 |
| 63 | ADRBK1 | 0.37622772 |
| 64 | STK3 | 0.37317992 |
| 65 | TIE1 | 0.36974472 |
| 66 | MELK | 0.36349314 |
| 67 | TBK1 | 0.36289641 |
| 68 | LMTK2 | 0.34836792 |
| 69 | CDK9 | 0.34574497 |
| 70 | CSF1R | 0.34325587 |
| 71 | PINK1 | 0.34110485 |
| 72 | PTK2 | 0.31748843 |
| 73 | MAPKAPK5 | 0.30784852 |
| 74 | PDK2 | 0.30604872 |
| 75 | HIPK2 | 0.29175860 |
| 76 | ILK | 0.28888198 |
| 77 | CSNK1D | 0.28316508 |
| 78 | CAMK2A | 0.27863742 |
| 79 | DYRK1A | 0.26501850 |
| 80 | MARK3 | 0.26396906 |
| 81 | MAP3K8 | 0.25375028 |
| 82 | PDK1 | 0.25051385 |
| 83 | PRKCZ | 0.20333746 |
| 84 | STK38 | 0.19457899 |
| 85 | CSNK1A1 | 0.19290578 |
| 86 | MAP2K4 | 0.18860993 |
| 87 | BRSK1 | 0.18506030 |
| 88 | CSNK2A1 | 0.18146239 |
| 89 | TXK | 0.17729706 |
| 90 | MUSK | 0.17312015 |
| 91 | IRAK4 | 0.17280155 |
| 92 | CAMK1 | 0.17237569 |
| 93 | MAPK8 | 0.16926054 |
| 94 | MKNK2 | 0.16810350 |
| 95 | CHEK2 | 0.15662211 |
| 96 | DAPK3 | 0.14970694 |
| 97 | CAMK2D | 0.14217231 |
| 98 | PRKCG | 0.14160042 |
| 99 | TTN | 0.13756646 |
| 100 | PRKAA2 | 0.13716260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 8.76679582 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.60650299 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.21835313 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.95661596 |
| 5 | Carbon metabolism_Homo sapiens_hsa01200 | 2.78430800 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.74905053 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31290641 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.02692964 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.00658419 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.86012531 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85737228 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72439700 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.63307298 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.59176369 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56018944 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.54117336 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20300297 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19035900 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16955129 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15695325 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14626981 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.13668917 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12948458 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12718741 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11265413 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.09044912 |
| 27 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.08579779 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06542583 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04982739 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03439049 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.03274666 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91393117 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91089403 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86807332 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86336519 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 0.83525341 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83013240 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81467604 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81362698 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80882057 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80154169 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77722721 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74674407 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73121814 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72200326 |
| 46 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70021849 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69997731 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69804702 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68817431 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68258714 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.66226287 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.66048186 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63920081 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.63566125 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62035525 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61694015 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61394056 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60564364 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59274446 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58636409 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57985935 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55673477 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53828583 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53595863 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51705025 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51615126 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50346268 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.46832196 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46587914 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.46133470 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45516583 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.42447839 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40342363 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39162579 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38901427 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37086769 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36880832 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.35162719 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33820868 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33490740 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.33437349 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33163418 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31420644 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30227402 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30095126 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27930821 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27076775 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.26603361 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26511822 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24837569 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24455272 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23557865 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22670416 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21923642 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.21179162 |
| 96 | DNA replication_Homo sapiens_hsa03030 | 0.20823059 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19611173 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18902280 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17375509 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16612357 |

